Literature DB >> 9610367

Molecular cloning of Saccharomyces cerevisiae MLF4/SSH4 gene which confers the immunosuppressant leflunomide resistance.

H Fujimura1.   

Abstract

Immunosuppressant leflunomide inhibits the growth of cytokine-stimulated lymphoid cells in vitro and also inhibits the growth of eukaryotic microorganism Saccharomyces cerevisiae. To elucidate the molecular mechanism of the action of the drug, a yeast gene which suppresses the anti-proliferative effect when in increased copy number was cloned and designated MLF4 for multicopy suppressor of leflunomide sensitivity. DNA sequencing analysis indicates that the MLF4 gene is identical to the SSH4 gene which suppresses the shr3 mutation. Excess of amino acids overcame the anti-proliferative activity of leflunomide. Thus, leflunomide is suggested to affect amino acid transport by interacting with Shr3 chaperon-like protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610367     DOI: 10.1006/bbrc.1998.8630

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Ear1p and Ssh4p are new adaptors of the ubiquitin ligase Rsp5p for cargo ubiquitylation and sorting at multivesicular bodies.

Authors:  Sébastien Léon; Zoi Erpapazoglou; Rosine Haguenauer-Tsapis
Journal:  Mol Biol Cell       Date:  2008-03-26       Impact factor: 4.138

2.  Ssh4, Rcr2 and Rcr1 affect plasma membrane transporter activity in Saccharomyces cerevisiae.

Authors:  Jhansi Kota; Monika Melin-Larsson; Per O Ljungdahl; Hanna Forsberg
Journal:  Genetics       Date:  2007-02-07       Impact factor: 4.562

3.  Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, alpha-helical, cationic peptides on Saccharomyces cerevisiae.

Authors:  C Oliver Morton; Andrew Hayes; Michael Wilson; Bharat M Rash; Stephen G Oliver; Peter Coote
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.